Sweetening Pharmaceutical Radiochemistry by <sup>18</sup>F-Fluoroglycosylation: Recent Progress and Future Prospects
In the field of <sup>18</sup>F-chemistry for the development of radiopharmaceuticals for positron emission tomography (PET), various labeling strategies by the use of prosthetic groups have been implemented, including chemoselective <sup>18</sup>F-labeling of biomolecules. Am...
Guardado en:
Autores principales: | Sandip S. Shinde, Simone Maschauer, Olaf Prante |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8f9d379a10724a7bad6cf05af0b0f11d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Advances in [<sup>18</sup>F]Trifluoromethylation Chemistry for PET Imaging
por: Felix Francis, et al.
Publicado: (2021) -
Diagnostic Performance of [<sup>18</sup>F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer
por: Ramsha Iqbal, et al.
Publicado: (2021) -
Comparison of Conventional and Radiomic Features between <sup>18</sup>F-FBPA PET/CT and PET/MR
por: Chien-Yi Liao, et al.
Publicado: (2021) -
Multiparametric Evaluation of Post-MI Small Animal Models Using Metabolic ([<sup>18</sup>F]FDG) and Perfusion-Based (SYN1) Heart Viability Tracers
por: Tomasz Jan Kolanowski, et al.
Publicado: (2021) -
Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [<sup>18</sup>F]FDG PET/CT in Metastatic Melanomas and Lung Cancer
por: Egesta Lopci
Publicado: (2021)